INS and Hypokalemia: The direct binding of SARS-CoV-2 to ACE2 on β-cells might contribute to β-cell damage and insulin deficiency, which, combined with cytokine-induced insulin resistance and hypokalemia-related inhibition of insulin secretion, contributes to worsening glucose control in patients with diabetes mellitus.